RodrÃguez, M.D.C.R.; RodrÃguez, I.G.; Nattress, C.; Qureshi, A.; Halldén, G.
HDAC Inhibitors Enhance Efficacy of the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T in Pancreatic and Triple-Negative Breast Cancer Models. Viruses 2022, 14, 1006.
https://doi.org/10.3390/v14051006
AMA Style
RodrÃguez MDCR, RodrÃguez IG, Nattress C, Qureshi A, Halldén G.
HDAC Inhibitors Enhance Efficacy of the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T in Pancreatic and Triple-Negative Breast Cancer Models. Viruses. 2022; 14(5):1006.
https://doi.org/10.3390/v14051006
Chicago/Turabian Style
RodrÃguez, MarÃa Del Carmen RodrÃguez, Inés GarcÃa RodrÃguez, Callum Nattress, Ahad Qureshi, and Gunnel Halldén.
2022. "HDAC Inhibitors Enhance Efficacy of the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T in Pancreatic and Triple-Negative Breast Cancer Models" Viruses 14, no. 5: 1006.
https://doi.org/10.3390/v14051006
APA Style
RodrÃguez, M. D. C. R., RodrÃguez, I. G., Nattress, C., Qureshi, A., & Halldén, G.
(2022). HDAC Inhibitors Enhance Efficacy of the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T in Pancreatic and Triple-Negative Breast Cancer Models. Viruses, 14(5), 1006.
https://doi.org/10.3390/v14051006